nodes	percent_of_prediction	percent_of_DWPC	metapath
Proguanil—CYP1A2—chronic obstructive pulmonary disease	0.403	1	CbGaD
Proguanil—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0571	0.12	CbGbCtD
Proguanil—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0421	0.0884	CbGbCtD
Proguanil—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0421	0.0884	CbGbCtD
Proguanil—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.035	0.0735	CbGbCtD
Proguanil—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.035	0.0735	CbGbCtD
Proguanil—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.033	0.0694	CbGbCtD
Proguanil—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.032	0.0672	CbGbCtD
Proguanil—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.032	0.0672	CbGbCtD
Proguanil—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0285	0.0599	CbGbCtD
Proguanil—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0269	0.0564	CbGbCtD
Proguanil—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0265	0.0557	CbGbCtD
Proguanil—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0181	0.0381	CbGbCtD
Proguanil—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0177	0.0371	CbGbCtD
Proguanil—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0173	0.0363	CbGbCtD
Proguanil—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0154	0.0324	CbGbCtD
Proguanil—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00906	0.019	CbGbCtD
Proguanil—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00855	0.0179	CbGbCtD
Proguanil—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.00153	0.0208	CcSEcCtD
Proguanil—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00131	0.0178	CcSEcCtD
Proguanil—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00131	0.0178	CcSEcCtD
Proguanil—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.00127	0.0173	CcSEcCtD
Proguanil—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.00126	0.0172	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00107	0.0145	CcSEcCtD
Proguanil—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.0138	CcSEcCtD
Proguanil—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.001	0.0136	CcSEcCtD
Proguanil—Stomatitis—Tiotropium—chronic obstructive pulmonary disease	0.000991	0.0135	CcSEcCtD
Proguanil—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000897	0.0122	CcSEcCtD
Proguanil—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00089	0.0121	CcSEcCtD
Proguanil—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000843	0.0115	CcSEcCtD
Proguanil—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000825	0.0112	CcSEcCtD
Proguanil—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000823	0.0112	CcSEcCtD
Proguanil—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000815	0.0111	CcSEcCtD
Proguanil—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.0008	0.0109	CcSEcCtD
Proguanil—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.000795	0.0108	CcSEcCtD
Proguanil—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.00076	0.0103	CcSEcCtD
Proguanil—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.000755	0.0103	CcSEcCtD
Proguanil—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000718	0.00976	CcSEcCtD
Proguanil—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000706	0.00959	CcSEcCtD
Proguanil—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000693	0.00943	CcSEcCtD
Proguanil—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000674	0.00917	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000672	0.00914	CcSEcCtD
Proguanil—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000665	0.00905	CcSEcCtD
Proguanil—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000665	0.00905	CcSEcCtD
Proguanil—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000664	0.00903	CcSEcCtD
Proguanil—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000664	0.00903	CcSEcCtD
Proguanil—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000656	0.00892	CcSEcCtD
Proguanil—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000656	0.00891	CcSEcCtD
Proguanil—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000652	0.00886	CcSEcCtD
Proguanil—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00065	0.00884	CcSEcCtD
Proguanil—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00065	0.00884	CcSEcCtD
Proguanil—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00065	0.00883	CcSEcCtD
Proguanil—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000646	0.00878	CcSEcCtD
Proguanil—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000645	0.00878	CcSEcCtD
Proguanil—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000645	0.00878	CcSEcCtD
Proguanil—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000641	0.00872	CcSEcCtD
Proguanil—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000641	0.00872	CcSEcCtD
Proguanil—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000636	0.00865	CcSEcCtD
Proguanil—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000632	0.0086	CcSEcCtD
Proguanil—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00063	0.00857	CcSEcCtD
Proguanil—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000628	0.00854	CcSEcCtD
Proguanil—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000627	0.00852	CcSEcCtD
Proguanil—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000613	0.00833	CcSEcCtD
Proguanil—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000609	0.00829	CcSEcCtD
Proguanil—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000606	0.00823	CcSEcCtD
Proguanil—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000598	0.00813	CcSEcCtD
Proguanil—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000562	0.00765	CcSEcCtD
Proguanil—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00056	0.00761	CcSEcCtD
Proguanil—Cough—Formoterol—chronic obstructive pulmonary disease	0.00056	0.00761	CcSEcCtD
Proguanil—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00056	0.00761	CcSEcCtD
Proguanil—Cough—Montelukast—chronic obstructive pulmonary disease	0.000548	0.00745	CcSEcCtD
Proguanil—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000544	0.00739	CcSEcCtD
Proguanil—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000544	0.00739	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000542	0.00737	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000542	0.00737	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000531	0.00722	CcSEcCtD
Proguanil—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00053	0.00721	CcSEcCtD
Proguanil—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000528	0.00719	CcSEcCtD
Proguanil—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000513	0.00698	CcSEcCtD
Proguanil—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000513	0.00698	CcSEcCtD
Proguanil—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000513	0.00697	CcSEcCtD
Proguanil—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000508	0.00691	CcSEcCtD
Proguanil—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000508	0.00691	CcSEcCtD
Proguanil—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000503	0.00684	CcSEcCtD
Proguanil—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000498	0.00677	CcSEcCtD
Proguanil—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000485	0.00659	CcSEcCtD
Proguanil—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00048	0.00653	CcSEcCtD
Proguanil—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000471	0.00641	CcSEcCtD
Proguanil—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000471	0.0064	CcSEcCtD
Proguanil—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000452	0.00614	CcSEcCtD
Proguanil—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000452	0.00614	CcSEcCtD
Proguanil—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000443	0.00602	CcSEcCtD
Proguanil—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000437	0.00595	CcSEcCtD
Proguanil—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000434	0.0059	CcSEcCtD
Proguanil—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000433	0.00589	CcSEcCtD
Proguanil—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000431	0.00586	CcSEcCtD
Proguanil—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00043	0.00584	CcSEcCtD
Proguanil—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000428	0.00582	CcSEcCtD
Proguanil—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000428	0.00582	CcSEcCtD
Proguanil—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.0058	CcSEcCtD
Proguanil—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000419	0.0057	CcSEcCtD
Proguanil—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000414	0.00563	CcSEcCtD
Proguanil—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000414	0.00563	CcSEcCtD
Proguanil—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000414	0.00563	CcSEcCtD
Proguanil—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000414	0.00563	CcSEcCtD
Proguanil—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000412	0.00561	CcSEcCtD
Proguanil—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000409	0.00556	CcSEcCtD
Proguanil—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000409	0.00556	CcSEcCtD
Proguanil—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000409	0.00555	CcSEcCtD
Proguanil—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000406	0.00552	CcSEcCtD
Proguanil—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000405	0.00551	CcSEcCtD
Proguanil—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000405	0.00551	CcSEcCtD
Proguanil—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000404	0.0055	CcSEcCtD
Proguanil—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.00531	CcSEcCtD
Proguanil—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.00531	CcSEcCtD
Proguanil—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000385	0.00524	CcSEcCtD
Proguanil—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.00487	CcSEcCtD
Proguanil—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000358	0.00487	CcSEcCtD
Proguanil—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000351	0.00477	CcSEcCtD
Proguanil—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000347	0.00472	CcSEcCtD
Proguanil—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.0046	CcSEcCtD
Proguanil—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000333	0.00453	CcSEcCtD
Proguanil—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.00453	CcSEcCtD
Proguanil—Rash—Formoterol—chronic obstructive pulmonary disease	0.00033	0.00449	CcSEcCtD
Proguanil—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.00449	CcSEcCtD
Proguanil—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00033	0.00448	CcSEcCtD
Proguanil—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.00448	CcSEcCtD
Proguanil—Headache—Formoterol—chronic obstructive pulmonary disease	0.000328	0.00446	CcSEcCtD
Proguanil—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000328	0.00446	CcSEcCtD
Proguanil—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000326	0.00443	CcSEcCtD
Proguanil—Rash—Montelukast—chronic obstructive pulmonary disease	0.000323	0.0044	CcSEcCtD
Proguanil—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000323	0.00439	CcSEcCtD
Proguanil—Headache—Montelukast—chronic obstructive pulmonary disease	0.000321	0.00437	CcSEcCtD
Proguanil—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.00427	CcSEcCtD
Proguanil—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.00424	CcSEcCtD
Proguanil—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.00423	CcSEcCtD
Proguanil—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000311	0.00423	CcSEcCtD
Proguanil—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.00423	CcSEcCtD
Proguanil—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.00421	CcSEcCtD
Proguanil—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000305	0.00414	CcSEcCtD
Proguanil—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.00399	CcSEcCtD
Proguanil—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000288	0.00392	CcSEcCtD
Proguanil—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000262	0.00356	CcSEcCtD
Proguanil—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000254	0.00345	CcSEcCtD
Proguanil—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000252	0.00343	CcSEcCtD
Proguanil—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000252	0.00343	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000213	0.0029	CcSEcCtD
Proguanil—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000202	0.00275	CcSEcCtD
Proguanil—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.0002	0.00272	CcSEcCtD
Proguanil—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000196	0.00267	CcSEcCtD
Proguanil—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000191	0.00408	CbGpPWpGaD
Proguanil—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000189	0.00404	CbGpPWpGaD
Proguanil—CYP2E1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000184	0.00394	CbGpPWpGaD
Proguanil—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000183	0.00391	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000181	0.00388	CbGpPWpGaD
Proguanil—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000181	0.00387	CbGpPWpGaD
Proguanil—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000179	0.00243	CcSEcCtD
Proguanil—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.00243	CcSEcCtD
Proguanil—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.00243	CcSEcCtD
Proguanil—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000178	0.00241	CcSEcCtD
Proguanil—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000171	0.00365	CbGpPWpGaD
Proguanil—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000168	0.00229	CcSEcCtD
Proguanil—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.00229	CcSEcCtD
Proguanil—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000167	0.00357	CbGpPWpGaD
Proguanil—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000166	0.00356	CbGpPWpGaD
Proguanil—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000166	0.00355	CbGpPWpGaD
Proguanil—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000163	0.00221	CcSEcCtD
Proguanil—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000163	0.00221	CcSEcCtD
Proguanil—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000162	0.00346	CbGpPWpGaD
Proguanil—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.00342	CbGpPWpGaD
Proguanil—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.00342	CbGpPWpGaD
Proguanil—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000158	0.00338	CbGpPWpGaD
Proguanil—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000156	0.00334	CbGpPWpGaD
Proguanil—DHFR—Folate Metabolism—TNF—chronic obstructive pulmonary disease	0.000155	0.00331	CbGpPWpGaD
Proguanil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00015	0.0032	CbGpPWpGaD
Proguanil—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000149	0.00318	CbGpPWpGaD
Proguanil—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000149	0.00318	CbGpPWpGaD
Proguanil—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000147	0.00315	CbGpPWpGaD
Proguanil—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000147	0.00314	CbGpPWpGaD
Proguanil—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000145	0.00311	CbGpPWpGaD
Proguanil—DHFR—Metabolism—APIP—chronic obstructive pulmonary disease	0.000144	0.00309	CbGpPWpGaD
Proguanil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000144	0.00308	CbGpPWpGaD
Proguanil—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000144	0.00307	CbGpPWpGaD
Proguanil—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000142	0.00304	CbGpPWpGaD
Proguanil—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000141	0.00192	CcSEcCtD
Proguanil—DHFR—Folate Metabolism—TP53—chronic obstructive pulmonary disease	0.000137	0.00292	CbGpPWpGaD
Proguanil—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000133	0.00284	CbGpPWpGaD
Proguanil—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00178	CcSEcCtD
Proguanil—Rash—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00177	CcSEcCtD
Proguanil—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00176	CcSEcCtD
Proguanil—Headache—Prednisone—chronic obstructive pulmonary disease	0.000129	0.00175	CcSEcCtD
Proguanil—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000128	0.00274	CbGpPWpGaD
Proguanil—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000126	0.00269	CbGpPWpGaD
Proguanil—DHFR—Folate Metabolism—IL6—chronic obstructive pulmonary disease	0.000125	0.00267	CbGpPWpGaD
Proguanil—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00166	CcSEcCtD
Proguanil—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.00259	CbGpPWpGaD
Proguanil—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.00258	CbGpPWpGaD
Proguanil—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000118	0.00252	CbGpPWpGaD
Proguanil—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000118	0.00251	CbGpPWpGaD
Proguanil—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000117	0.0025	CbGpPWpGaD
Proguanil—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000115	0.00246	CbGpPWpGaD
Proguanil—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000113	0.00242	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.00237	CbGpPWpGaD
Proguanil—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.00237	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.00237	CbGpPWpGaD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	0.000109	0.00234	CbGpPWpGaD
Proguanil—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000109	0.00233	CbGpPWpGaD
Proguanil—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000108	0.00231	CbGpPWpGaD
Proguanil—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000106	0.00227	CbGpPWpGaD
Proguanil—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000106	0.00226	CbGpPWpGaD
Proguanil—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000105	0.00224	CbGpPWpGaD
Proguanil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.00224	CbGpPWpGaD
Proguanil—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.00223	CbGpPWpGaD
Proguanil—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.00221	CbGpPWpGaD
Proguanil—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.00221	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.72e-05	0.00208	CbGpPWpGaD
Proguanil—DHFR—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.56e-05	0.00204	CbGpPWpGaD
Proguanil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	9.51e-05	0.00203	CbGpPWpGaD
Proguanil—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	9.38e-05	0.00201	CbGpPWpGaD
Proguanil—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.31e-05	0.00199	CbGpPWpGaD
Proguanil—DHFR—Metabolism—GC—chronic obstructive pulmonary disease	9.3e-05	0.00199	CbGpPWpGaD
Proguanil—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.95e-05	0.00191	CbGpPWpGaD
Proguanil—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.83e-05	0.00189	CbGpPWpGaD
Proguanil—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.82e-05	0.00189	CbGpPWpGaD
Proguanil—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.7e-05	0.00186	CbGpPWpGaD
Proguanil—DHFR—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.64e-05	0.00185	CbGpPWpGaD
Proguanil—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.57e-05	0.00183	CbGpPWpGaD
Proguanil—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.54e-05	0.00183	CbGpPWpGaD
Proguanil—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.49e-05	0.00182	CbGpPWpGaD
Proguanil—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.19e-05	0.00175	CbGpPWpGaD
Proguanil—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.1e-05	0.00173	CbGpPWpGaD
Proguanil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	7.71e-05	0.00165	CbGpPWpGaD
Proguanil—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	7.56e-05	0.00162	CbGpPWpGaD
Proguanil—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.53e-05	0.00161	CbGpPWpGaD
Proguanil—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.47e-05	0.0016	CbGpPWpGaD
Proguanil—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.45e-05	0.00159	CbGpPWpGaD
Proguanil—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.38e-05	0.00158	CbGpPWpGaD
Proguanil—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.36e-05	0.00157	CbGpPWpGaD
Proguanil—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.26e-05	0.00155	CbGpPWpGaD
Proguanil—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.26e-05	0.00155	CbGpPWpGaD
Proguanil—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	6.95e-05	0.00149	CbGpPWpGaD
Proguanil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.91e-05	0.00148	CbGpPWpGaD
Proguanil—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.82e-05	0.00146	CbGpPWpGaD
Proguanil—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.81e-05	0.00146	CbGpPWpGaD
Proguanil—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.76e-05	0.00145	CbGpPWpGaD
Proguanil—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.71e-05	0.00144	CbGpPWpGaD
Proguanil—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.67e-05	0.00143	CbGpPWpGaD
Proguanil—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.41e-05	0.00137	CbGpPWpGaD
Proguanil—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.38e-05	0.00137	CbGpPWpGaD
Proguanil—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.32e-05	0.00135	CbGpPWpGaD
Proguanil—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.31e-05	0.00135	CbGpPWpGaD
Proguanil—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.26e-05	0.00134	CbGpPWpGaD
Proguanil—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.21e-05	0.00133	CbGpPWpGaD
Proguanil—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.18e-05	0.00132	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	6.13e-05	0.00131	CbGpPWpGaD
Proguanil—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.12e-05	0.00131	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.76e-05	0.00123	CbGpPWpGaD
Proguanil—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.68e-05	0.00121	CbGpPWpGaD
Proguanil—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.6e-05	0.0012	CbGpPWpGaD
Proguanil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.6e-05	0.0012	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.25e-05	0.00112	CbGpPWpGaD
Proguanil—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.22e-05	0.00112	CbGpPWpGaD
Proguanil—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.22e-05	0.00112	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	5.19e-05	0.00111	CbGpPWpGaD
Proguanil—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.18e-05	0.00111	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	5.16e-05	0.0011	CbGpPWpGaD
Proguanil—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.15e-05	0.0011	CbGpPWpGaD
Proguanil—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.15e-05	0.0011	CbGpPWpGaD
Proguanil—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.11e-05	0.00109	CbGpPWpGaD
Proguanil—DHFR—Disease—HDAC2—chronic obstructive pulmonary disease	5.1e-05	0.00109	CbGpPWpGaD
Proguanil—DHFR—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.08e-05	0.00109	CbGpPWpGaD
Proguanil—DHFR—Metabolism—GCLC—chronic obstructive pulmonary disease	5.02e-05	0.00107	CbGpPWpGaD
Proguanil—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.95e-05	0.00106	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.93e-05	0.00105	CbGpPWpGaD
Proguanil—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.88e-05	0.00104	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.87e-05	0.00104	CbGpPWpGaD
Proguanil—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.8e-05	0.00103	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.76e-05	0.00102	CbGpPWpGaD
Proguanil—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.76e-05	0.00102	CbGpPWpGaD
Proguanil—DHFR—Disease—KL—chronic obstructive pulmonary disease	4.74e-05	0.00101	CbGpPWpGaD
Proguanil—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.73e-05	0.00101	CbGpPWpGaD
Proguanil—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.69e-05	0.001	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.67e-05	0.000998	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.67e-05	0.000998	CbGpPWpGaD
Proguanil—DHFR—Metabolism—CTGF—chronic obstructive pulmonary disease	4.58e-05	0.00098	CbGpPWpGaD
Proguanil—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.55e-05	0.000973	CbGpPWpGaD
Proguanil—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.51e-05	0.000965	CbGpPWpGaD
Proguanil—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.49e-05	0.00096	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.49e-05	0.00096	CbGpPWpGaD
Proguanil—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.45e-05	0.000951	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	4.44e-05	0.000951	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	4.44e-05	0.000951	CbGpPWpGaD
Proguanil—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.42e-05	0.000946	CbGpPWpGaD
Proguanil—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.36e-05	0.000933	CbGpPWpGaD
Proguanil—DHFR—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.22e-05	0.000903	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.09e-05	0.000876	CbGpPWpGaD
Proguanil—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.07e-05	0.00087	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.04e-05	0.000864	CbGpPWpGaD
Proguanil—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.01e-05	0.000858	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.98e-05	0.000851	CbGpPWpGaD
Proguanil—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.85e-05	0.000824	CbGpPWpGaD
Proguanil—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.8e-05	0.000813	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.66e-05	0.000783	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.63e-05	0.000776	CbGpPWpGaD
Proguanil—DHFR—Disease—ERBB3—chronic obstructive pulmonary disease	3.55e-05	0.00076	CbGpPWpGaD
Proguanil—DHFR—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.52e-05	0.000753	CbGpPWpGaD
Proguanil—DHFR—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.47e-05	0.000743	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.42e-05	0.000731	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.41e-05	0.00073	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.37e-05	0.00072	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	3.32e-05	0.000711	CbGpPWpGaD
Proguanil—DHFR—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.24e-05	0.000692	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.14e-05	0.000671	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	3.1e-05	0.000663	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.09e-05	0.000662	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.09e-05	0.000661	CbGpPWpGaD
Proguanil—DHFR—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.07e-05	0.000656	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.97e-05	0.000636	CbGpPWpGaD
Proguanil—DHFR—Disease—NOS2—chronic obstructive pulmonary disease	2.96e-05	0.000633	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.93e-05	0.000627	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.84e-05	0.000607	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.64e-05	0.000564	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.61e-05	0.000559	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.59e-05	0.000553	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.56e-05	0.000548	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—TP53—chronic obstructive pulmonary disease	2.53e-05	0.00054	CbGpPWpGaD
Proguanil—DHFR—Disease—SERPINE1—chronic obstructive pulmonary disease	2.49e-05	0.000533	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.42e-05	0.000519	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.4e-05	0.000514	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.39e-05	0.000512	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.38e-05	0.00051	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.38e-05	0.00051	CbGpPWpGaD
Proguanil—DHFR—Disease—NOS3—chronic obstructive pulmonary disease	2.38e-05	0.000509	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.36e-05	0.000504	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.34e-05	0.0005	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.21e-05	0.000473	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.19e-05	0.000469	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.17e-05	0.000465	CbGpPWpGaD
Proguanil—DHFR—Metabolism—ALB—chronic obstructive pulmonary disease	2.08e-05	0.000446	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.05e-05	0.000439	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	2e-05	0.000427	CbGpPWpGaD
Proguanil—DHFR—Metabolism—NOS3—chronic obstructive pulmonary disease	1.99e-05	0.000426	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.9e-05	0.000406	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.86e-05	0.000397	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.82e-05	0.000388	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.79e-05	0.000384	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.73e-05	0.00037	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.64e-05	0.00035	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.59e-05	0.000339	CbGpPWpGaD
Proguanil—DHFR—Disease—TGFB1—chronic obstructive pulmonary disease	1.57e-05	0.000337	CbGpPWpGaD
Proguanil—DHFR—Disease—EGFR—chronic obstructive pulmonary disease	1.54e-05	0.00033	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.54e-05	0.00033	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.51e-05	0.000323	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.48e-05	0.000317	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.43e-05	0.000307	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.4e-05	0.0003	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.38e-05	0.000296	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.29e-05	0.000276	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.29e-05	0.000276	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.28e-05	0.000273	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.27e-05	0.000272	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.26e-05	0.00027	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.26e-05	0.00027	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.26e-05	0.000269	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.24e-05	0.000265	CbGpPWpGaD
Proguanil—DHFR—Disease—IL6—chronic obstructive pulmonary disease	1.19e-05	0.000254	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.18e-05	0.000252	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.16e-05	0.000249	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.16e-05	0.000249	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.16e-05	0.000247	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.15e-05	0.000246	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.1e-05	0.000235	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.09e-05	0.000233	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.08e-05	0.000231	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.07e-05	0.000229	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.06e-05	0.000227	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.01e-05	0.000215	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	9.85e-06	0.000211	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.71e-06	0.000208	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.58e-06	0.000205	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.93e-06	0.000191	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.92e-06	0.000191	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.85e-06	0.000189	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.81e-06	0.000188	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.73e-06	0.000187	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.46e-06	0.000181	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.42e-06	0.00018	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.33e-06	0.000178	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.21e-06	0.000176	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.14e-06	0.000174	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.78e-06	0.000166	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.71e-06	0.000165	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.6e-06	0.000163	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.57e-06	0.000162	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.46e-06	0.00016	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	7.45e-06	0.000159	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.13e-06	0.000152	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7e-06	0.00015	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.95e-06	0.000149	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.59e-06	0.000141	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.84e-06	0.000125	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.76e-06	0.000123	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	5.75e-06	0.000123	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	5.5e-06	0.000118	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.37e-06	0.000115	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	5.29e-06	0.000113	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	5.24e-06	0.000112	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.09e-06	0.000109	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.06e-06	0.000108	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	5.02e-06	0.000107	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.48e-06	9.58e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.29e-06	9.17e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.46e-06	7.4e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.31e-06	7.07e-05	CbGpPWpGaD
